AbbVie Non-GAAP EPS of $2.16 misses by $0.10, revenue of $15.1B beats by $270M (NYSE:ABBV)January 31, 2025
Market Trends Mesoblast reports Q2 results | Seeking AlphaBy admin8996erT0allJanuary 31, 2025 Mesoblast press release (NASDAQ:MESO): Q2 net operating cash spend was $10.1 million. Net operating cash spend for the quarter was reduced…
Market Trends Mesoblast to join Nasdaq Biotechnology Index (NASDAQ:MESO)By admin8996erT0allDecember 18, 2024 Mesoblast (NASDAQ:MESO) is set to join the Nasdaq Biotechnology Index, effective after U.S. market open on Dec. 23, 2024. The…
